These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Donepezil use in the treatment of dementia associated with Down syndrome. Cipriani G; Bianchetti A; Trabucchi M Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720 [No Abstract] [Full Text] [Related]
4. Neuroleptic malignant-like syndrome due to donepezil and maprotiline. Ohkoshi N; Satoh D; Nishi M; Shoji S Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986 [No Abstract] [Full Text] [Related]
5. Donepezil for Alzheimer's disease. Benjamin B; Burns A Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763 [TBL] [Abstract][Full Text] [Related]
6. Donepezil in the treatment of hallucinations and delusions in Parkinson's disease. Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Lenzi GL; Meco G Neurol Sci; 2002 Apr; 23(1):41-3. PubMed ID: 12111620 [TBL] [Abstract][Full Text] [Related]
7. Treatment of typical Charles Bonnet syndrome with donepezil. Ukai S; Yamamoto M; Tanaka M; Takeda M Int Clin Psychopharmacol; 2004 Nov; 19(6):355-7. PubMed ID: 15486523 [TBL] [Abstract][Full Text] [Related]
9. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA]. Azanza JR; Sádaba B; Quetglas EG; Escolar M Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948 [No Abstract] [Full Text] [Related]
10. Successful treatment of musical hallucinations with the acetylcholinesterase inhibitor donepezil. Zilles D; Zerr I; Wedekind D J Clin Psychopharmacol; 2012 Jun; 32(3):422-4. PubMed ID: 22561476 [No Abstract] [Full Text] [Related]
13. The emergence of pharmacotherapies for cognitive function in Down syndrome. Capone GT Am J Med Genet A; 2010 Dec; 152A(12):3026-7. PubMed ID: 21108389 [No Abstract] [Full Text] [Related]
14. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report. Miyaoka T; Seno H; Yamamori C; Inagaki T; Itoga M; Tsubouchi K; Horiguchi J J Clin Psychiatry; 2001 Jul; 62(7):573-4. PubMed ID: 11488374 [No Abstract] [Full Text] [Related]
15. [Post-marketing observational study of donepezil]. Ibach B Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820 [No Abstract] [Full Text] [Related]
16. A 10-year perspective on donepezil. Cheewakriengkrai L; Gauthier S Expert Opin Pharmacother; 2013 Feb; 14(3):331-8. PubMed ID: 23316713 [TBL] [Abstract][Full Text] [Related]
18. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study. Prasher VP; Adams C; Holder R; Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681 [No Abstract] [Full Text] [Related]
19. Donepezil for nursing home patients with dementia: a reinterpretation of the evidence. Steinman MA; Covinsky KE J Am Geriatr Soc; 2003 Jan; 51(1):132; author reply 132-3. PubMed ID: 12534859 [No Abstract] [Full Text] [Related]
20. Abnormal movements with donepezil in Alzheimer disease. Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc JL; Moulias S; Vellas B Ann Pharmacother; 2000 Nov; 34(11):1347. PubMed ID: 11098352 [No Abstract] [Full Text] [Related] [Next] [New Search]